1
|
Erdmann M, Hodgson L, Webb I, Davidson AD, Verkade P. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) culture and sample preparation for correlative light electron microscopy. Methods Cell Biol 2024; 187:99-116. [PMID: 38705632 DOI: 10.1016/bs.mcb.2024.02.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/07/2024]
Abstract
Correlative Light Electron Microscopy (CLEM) is a powerful technique to investigate the ultrastructure of specific cells and organelles at sub-cellular resolution. Transmission Electron Microscopy (TEM) is particularly useful to the field of virology, given the small size of the virion, which is below the limit of detection by light microscopy. Furthermore, viral infection results in the rearrangement of host organelles to form spatially defined compartments that facilitate the replication of viruses. With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there has been great interest to study the viral replication complex using CLEM. In this chapter we provide an exemplary workflow describing the safe preparation and processing of cells grown on coverslips and infected with SARS-CoV-2.
Collapse
Affiliation(s)
- Maximilian Erdmann
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Lorna Hodgson
- Wolfson Bioimaging Facility, University of Bristol, Bristol, United Kingdom
| | - Isobel Webb
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Andrew D Davidson
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
| | - Paul Verkade
- School of Biochemistry, University of Bristol, Bristol, United Kingdom.
| |
Collapse
|
2
|
Lusby E, Gibson J, Leckie T, Newton R, Hodgson L. Paediatric non-theatre emergency airway management. Anaesthesia 2024; 79:206-207. [PMID: 37946518 DOI: 10.1111/anae.16167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/16/2023] [Indexed: 11/12/2023]
Affiliation(s)
- E Lusby
- University Hospitals Sussex NHS Foundation Trust, Brighton, UK
| | - J Gibson
- University Hospitals Sussex NHS Foundation Trust, Brighton, UK
| | - T Leckie
- University Hospitals Sussex NHS Foundation Trust, Worthing, UK
| | - R Newton
- University Hospitals Sussex NHS Foundation Trust, Brighton, UK
| | - L Hodgson
- University Hospitals Sussex NHS Foundation Trust, Worthing, UK
| |
Collapse
|
3
|
Zedler JAZ, Schirmacher AM, Russo DA, Hodgson L, Gundersen E, Matthes A, Frank S, Verkade P, Jensen PE. Self-Assembly of Nanofilaments in Cyanobacteria for Protein Co-localization. ACS Nano 2023; 17:25279-25290. [PMID: 38065569 PMCID: PMC10754207 DOI: 10.1021/acsnano.3c08600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2023] [Revised: 11/12/2023] [Accepted: 11/15/2023] [Indexed: 12/27/2023]
Abstract
Cyanobacteria offer great potential as alternative biotechnological hosts due to their photoautotrophic capacities. However, in comparison to established heterotrophic hosts, several key aspects, such as product titers, are still lagging behind. Nanobiotechnology is an emerging field with great potential to improve existing hosts, but so far, it has barely been explored in microbial photosynthetic systems. Here, we report the establishment of large proteinaceous nanofilaments in the unicellular model cyanobacterium Synechocystis sp. PCC 6803 and the fast-growing cyanobacterial strain Synechococcus elongatus UTEX 2973. Transmission electron microscopy and electron tomography demonstrated that expression of pduA*, encoding a modified bacterial microcompartment shell protein, led to the generation of bundles of longitudinally aligned nanofilaments in S. elongatus UTEX 2973 and shorter filamentous structures in Synechocystis sp. PCC 6803. Comparative proteomics showed that PduA* was at least 50 times more abundant than the second most abundant protein in the cell and that nanofilament assembly had only a minor impact on cellular metabolism. Finally, as a proof-of-concept for co-localization with the filaments, we targeted a fluorescent reporter protein, mCitrine, to PduA* by fusion with an encapsulation peptide that natively interacts with PduA. The establishment of nanofilaments in cyanobacterial cells is an important step toward cellular organization of heterologous pathways and the establishment of cyanobacteria as next-generation hosts.
Collapse
Affiliation(s)
- Julie A. Z. Zedler
- Synthetic
Biology of Photosynthetic Organisms, Matthias Schleiden Institute
for Genetics, Bioinformatics and Molecular Botany, Friedrich Schiller University Jena, 07743 Jena, Germany
| | - Alexandra M. Schirmacher
- Synthetic
Biology of Photosynthetic Organisms, Matthias Schleiden Institute
for Genetics, Bioinformatics and Molecular Botany, Friedrich Schiller University Jena, 07743 Jena, Germany
| | - David A. Russo
- Bioorganic
Analytics, Institute for Inorganic and Analytical Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany
| | - Lorna Hodgson
- School
of Biochemistry, University of Bristol, Bristol, BS8 1TD, United Kingdom
| | - Emil Gundersen
- Department
of Plant and Environmental Sciences, University
of Copenhagen, 1871 Frederiksberg, Denmark
| | - Annemarie Matthes
- Department
of Plant and Environmental Sciences, University
of Copenhagen, 1871 Frederiksberg, Denmark
| | - Stefanie Frank
- Department
of Biochemical Engineering, University College
London, London, WC1E 6BT, United
Kingdom
| | - Paul Verkade
- School
of Biochemistry, University of Bristol, Bristol, BS8 1TD, United Kingdom
| | - Poul Erik Jensen
- Department
of Food Science, University of Copenhagen, 1958 Frederiksberg, Denmark
| |
Collapse
|
4
|
Stacey MJ, Leckie T, Fitzpatrick D, Hodgson L, Barden A, Jenkins R, Galloway R, Weller C, Grivas GV, Pitsiladis Y, Richardson AJ, Woods DR. Neurobiomarker and body temperature responses to recreational marathon running. J Sci Med Sport 2023; 26:566-573. [PMID: 37777396 DOI: 10.1016/j.jsams.2023.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 09/11/2023] [Accepted: 09/17/2023] [Indexed: 10/02/2023]
Abstract
OBJECTIVES To assess how biomarkers indicating central nervous system insult (neurobiomarkers) vary in peripheral blood with exertional-heat stress from prolonged endurance exercise. DESIGN Observational study of changes in neuron specific enolase (NSE), S100 calcium-binding protein B (S100β), Glial Fibrillary Acid Protein (GFAP) and Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) at Brighton Marathon 2022. METHODS In 38 marathoners with in-race core temperature (Tc) monitoring, exposure (High, Intermediate or Low) was classified by cumulative hyperthermia - calculated as area under curve of Time × Tc > 38 °C - and also by running duration (finishing time). Blood was sampled for neurobiomarkers, cortisol and fluid-regulatory stress surrogates, including copeptin and creatinine (at rested baseline; within 30 min of finishing; and at 24 h). RESULTS Finishing in 236 ± 40 min, runners showed stable GFAP and UCH-L1 across the marathon and next-day. Significant (P < 0.05) increases from baseline were shown post-marathon and at 24 h for S100β (8.52 [3.65, 22.95] vs 39.0 [26.48, 52.33] vs 80.3 [49.1, 99.7] ng·L-1) and post-marathon only for NSE (3.73 [3.30, 4.32] vs 4.85 [4.45, 5.80] μg·L-1, P < 0.0001). Whilst differential response to hyperthermia was observed for cortisol, copeptin and creatinine, neurobiomarker responses did not vary. Post-marathon, only NSE differed by exercise duration (High vs Low, 5.81 ± 1.77 vs. 4.69 ± 0.73 μg·L-1, adjusted P = 0.0358). CONCLUSIONS Successful marathon performance did not associate with evidence for substantial neuronal insult. To account for variation in neurobiomarkers with prolonged endurance exercise, factors additional to hyperthermia, such as exercise duration and intensity, should be further investigated.
Collapse
Affiliation(s)
- M J Stacey
- Academic Department of Military Medicine, Defence Medical Services, UK; Carnegie School of Sport, Leeds Beckett University, UK; Department of Surgery and Cancer, Imperial College London, UK.
| | - T Leckie
- School of Sport and Health Sciences, University of Brighton, UK
| | - D Fitzpatrick
- School of Sport and Health Sciences, University of Brighton, UK; Sport and Exercise Medicine Department, Charing Cross Hospital, UK
| | - L Hodgson
- Brighton & Sussex Medical School, Brighton, UK
| | - A Barden
- School of Medicine, Imperial College London, UK
| | - R Jenkins
- Foundation Programme, Defence Medical Services, UK
| | - R Galloway
- Brighton & Sussex Medical School, Brighton, UK
| | - C Weller
- Brighton & Sussex Medical School, Brighton, UK
| | - G V Grivas
- Division of Humanities and Political Sciences, Physical Education and Sports, Hellenic Naval Academy, Greece
| | - Y Pitsiladis
- School of Sport and Health Sciences, University of Brighton, UK; Human Telemetrics, UK
| | - A J Richardson
- School of Sport and Health Sciences, University of Brighton, UK
| | - D R Woods
- Academic Department of Military Medicine, Defence Medical Services, UK; Carnegie School of Sport, Leeds Beckett University, UK
| |
Collapse
|
5
|
Gibson J, Leckie T, Hayward J, Hodgson L. Non-theatre emergency airway management: a multicentre prospective observational study. Anaesthesia 2023; 78:1338-1346. [PMID: 37549371 DOI: 10.1111/anae.16107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/10/2023] [Indexed: 08/09/2023]
Abstract
Emergency airway management events are common, unpredictable and associated with high complication rates. This multicentre prospective observational study across eight acute NHS hospitals in southeast England reports the incidence and nature of non-theatre emergency airway management events. Data were collected from non-theatre emergency airway management, including adverse events, over a continuous 28-day window, and recorded on an electronic case report form. Events were classified according to type (advanced airway; simple airway; and cardiac arrest). A total of 166 events were recorded, with 111 advanced airway events involving tracheal intubation or tracheostomy management. Senior personnel with three or more years of airway management experience were present for 105/111 (95%) advanced airway management episodes. There was a significant reduction in consultant or equivalent presence out-of-hours (21/64, 33%) vs. in-hours (34/47, 72%) (p < 0.001). We found high utilisation of videolaryngoscopy (95/106, 90%) and universal use of capnography for all advanced airway management events. This was lower during cardiac arrest when videolaryngoscopy was used in 11/16 (69%) of tracheal intubations and capnography in 21/32 (66%) of all cardiac arrest episodes. Adverse outcomes during advanced airway management (excluding during cardiac arrest) occurred in 53/111 (48%) episodes, including hypoxia (desaturation to Sp O2 < 80% in 14/111, 13%) and hypotension (systolic blood pressure < 80 mmHg in 27/111, 25%). Adverse outcomes were not associated with time of day or experience level of airway practitioners. We conclude that there is a disparity between consultant presence for advanced airway interventions in- and out-of-hours; high utilisation of videolaryngoscopy and capnography, especially for advanced airway interventions; and a high incidence of hypotension and hypoxaemia, including critical values, during non-theatre airway management.
Collapse
Affiliation(s)
- J Gibson
- Department of Anaesthetics and Intensive Care Medicine, Surrey and Sussex Healthcare NHS Trust, Redhill, Surrey, UK
| | - T Leckie
- Department of Anaesthetics and Intensive Care Medicine, University Hospitals Sussex NHS Foundation Trust, Worthing, Sussex, UK
- Department of Anaesthetics and Intensive Care Medicine, University Hospitals Sussex NHS Foundation Trust, Worthing, Sussex, UK
| | - J Hayward
- Department of Anaesthetics and Intensive Care Medicine, University Hospitals Sussex NHS Foundation Trust, Worthing, Sussex, UK
| | - L Hodgson
- Department of Anaesthetics and Intensive Care Medicine, University Hospitals Sussex NHS Foundation Trust, Worthing, Sussex, UK
- Brighton and Sussex Medical School, Brighton, UK
| |
Collapse
|
6
|
Toelzer C, Gupta K, Yadav SKN, Hodgson L, Williamson MK, Buzas D, Borucu U, Powers K, Stenner R, Vasileiou K, Garzoni F, Fitzgerald D, Payré C, Gautam G, Lambeau G, Davidson AD, Verkade P, Frank M, Berger I, Schaffitzel C. The free fatty acid-binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron. Sci Adv 2022; 8:eadc9179. [PMID: 36417532 PMCID: PMC9683698 DOI: 10.1126/sciadv.adc9179] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2022] [Accepted: 10/19/2022] [Indexed: 06/01/2023]
Abstract
As coronavirus disease 2019 (COVID-19) persists, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) emerge, accumulating spike (S) glycoprotein mutations. S receptor binding domain (RBD) comprises a free fatty acid (FFA)-binding pocket. FFA binding stabilizes a locked S conformation, interfering with virus infectivity. We provide evidence that the pocket is conserved in pathogenic β-coronaviruses (β-CoVs) infecting humans. SARS-CoV, MERS-CoV, SARS-CoV-2, and VOCs bind the essential FFA linoleic acid (LA), while binding is abolished by one mutation in common cold-causing HCoV-HKU1. In the SARS-CoV S structure, LA stabilizes the locked conformation, while the open, infectious conformation is devoid of LA. Electron tomography of SARS-CoV-2-infected cells reveals that LA treatment inhibits viral replication, resulting in fewer deformed virions. Our results establish FFA binding as a hallmark of pathogenic β-CoV infection and replication, setting the stage for FFA-based antiviral strategies to overcome COVID-19.
Collapse
Affiliation(s)
- Christine Toelzer
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Kapil Gupta
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
- Imophoron Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK
| | - Sathish K. N. Yadav
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Lorna Hodgson
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | | | - Dora Buzas
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
- Max Planck Bristol Centre for Minimal Biology, Cantock’s Close, Bristol BS8 1TS, UK
| | - Ufuk Borucu
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Kyle Powers
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Richard Stenner
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Kate Vasileiou
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Frederic Garzoni
- Imophoron Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK
| | - Daniel Fitzgerald
- Halo Therapeutics Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK
| | - Christine Payré
- Université Côte d’Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne Sophia Antipolis, France
| | - Gunjan Gautam
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | - Gérard Lambeau
- Université Côte d’Azur, Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne Sophia Antipolis, France
| | - Andrew D. Davidson
- Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, UK
| | - Paul Verkade
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
| | | | - Imre Berger
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
- Max Planck Bristol Centre for Minimal Biology, Cantock’s Close, Bristol BS8 1TS, UK
- Halo Therapeutics Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK
- School of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, UK
| | - Christiane Schaffitzel
- School of Biochemistry, University of Bristol, 1 Tankard’s Close, Bristol BS8 1TD, UK
- Bristol Synthetic Biology Centre BrisSynBio, 24 Tyndall Ave, Bristol BS8 1TQ, UK
- Halo Therapeutics Ltd., St. Philips Central, Albert Rd, Bristol BS2 0XJ, UK
| |
Collapse
|
7
|
Abstract
Correlative Imaging (CI) visualizes a single sample/region of interest with two or more imaging modalities. The technique seeks to elucidate information that may not be discernible by using either of the constituent techniques in isolation. Correlative Light Electron Microscopy (CLEM) can be employed to streamline workflows, i.e., using fluorescent signals in the light microscope (LM) to inform the user of regions which should be imaged with electron microscopy (EM). The efficacy of correlative techniques requires high spatial resolution of signals from both imaging modalities. Ideally, a single point should originate from both the fluorescence and electron density. However, many of the ubiquitously used probes have a significant distance between their fluorescence and electron dense portions. Furthermore, electron dense metal nanoparticles used for EM visualization readily quench any proximal adjacent fluorophores. Therefore, accurate registration of both signals becomes difficult. Here we describe fluorescent nanoclusters in the context of a CLEM probe as they are composed of several atoms of a noble metal, in this case platinum, providing electron density. In addition, their structure confers them with fluorescence via a mechanism analogous to quantum dots. The electron dense core gives rise to the fluorescence which enables highly accurate signal registration between epifluorescence and electron imaging modalities. We provide a protocol for the synthesis of the nanoclusters with some additional techniques for their characterization and finally show how they can be used in a CLEM set up.
Collapse
Affiliation(s)
- Hugh Tanner
- School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, United Kingdom
| | - Lorna Hodgson
- School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, United Kingdom
| | - Judith Mantell
- School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, United Kingdom
| | - Paul Verkade
- School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, United Kingdom.
| |
Collapse
|
8
|
Shewring JR, Hodgson L, Bryant HL, Bullough PA, Weinstein JA, Verkade P. Refining a correlative light electron microscopy workflow using luminescent metal complexes. Methods Cell Biol 2021; 162:69-87. [PMID: 33707023 DOI: 10.1016/bs.mcb.2020.12.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The potential for increasing the application of Correlative Light Electron Microscopy (CLEM) technologies in life science research is hindered by the lack of suitable molecular probes that are emissive, photostable, and scatter electrons well. Most brightly fluorescent organic molecules are intrinsically poor electron-scatterers, while multi-metallic compounds scatter electrons well but are usually non-luminescent. Thus, the goal of CLEM to image the same object of interest on the continuous scale from hundreds of microns to nanometers remains a major challenge partially due to requirements for a single probe to be suitable for light (LM) and electron microscopy (EM). Some of the main CLEM probes, based on gold nanoparticles appended with fluorophores and quantum dots (QD) have presented significant drawbacks. Here we present an Iridium-based luminescent metal complex (Ir complex 1) as a probe and describe how we have developed a CLEM workflow based on such metal complexes.
Collapse
Affiliation(s)
| | - Lorna Hodgson
- School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, United Kingdom
| | - Helen L Bryant
- Department of Oncology, University of Sheffield, Sheffield, United Kingdom
| | - Per A Bullough
- Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, United Kingdom
| | - Julia A Weinstein
- Department of Chemistry, University of Sheffield, Sheffield, United Kingdom
| | - Paul Verkade
- School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, United Kingdom.
| |
Collapse
|
9
|
Street STG, He Y, Jin XH, Hodgson L, Verkade P, Manners I. Cellular uptake and targeting of low dispersity, dual emissive, segmented block copolymer nanofibers. Chem Sci 2020; 11:8394-8408. [PMID: 34094184 PMCID: PMC8162143 DOI: 10.1039/d0sc02593c] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Accepted: 07/03/2020] [Indexed: 11/21/2022] Open
Abstract
Polymer-based nanoparticles show substantial promise in the treatment and diagnosis of cancer and other diseases. Herein we report an exploration of the cellular uptake of tailored, low dispersity segmented 1D nanoparticles which were prepared from an amphiphilic block copolymer, poly(dihexylfluorene)-b-poly(ethyleneglycol) (PDHF13-b-PEG227), with a crystallizable PDHF core-forming block and a 'stealth' PEG corona-forming block with different end-group functionalities. Segmented C-B-A-B-C pentablock 1D nanofibers with varied spatially-defined coronal chemistries and a selected length (95 nm) were prepared using the living crystallization-driven self-assembly (CDSA) seeded-growth method. As the blue fluorescence of PDHF is often subject to environment-related quenching, a far-red BODIPY (BD) fluorophore was attached to the PEG end-group of the coronal B segments to provide additional tracking capability. Folic acid (FA) was also incorporated as a targeting group in the terminal C segments. These dual-emissive pentablock nanofibers exhibited uptake into >97% of folate receptor positive HeLa cells by flow cytometry. In the absence of FA, no significant uptake was detected and nanofibers with either FA or BD coronal groups showed no significant toxicity. Correlative light and electron microscopy (CLEM) studies revealed receptor-mediated endocytosis as an uptake pathway, with subsequent localization to the perinuclear region. A significant proportion of the nanofibers also appeared to interact with the cell membrane in an end-on fashion, which was coupled with fluorescence quenching of the PDHF core. These results provide new insights into the cellular uptake of polymer-based nanofibers and suggest their potential use in targeted therapies and diagnostics.
Collapse
Affiliation(s)
- Steven T G Street
- School of Chemistry, University of Bristol Bristol BS8 1TS UK
- Department of Chemistry, University of Victoria Victoria BC V8W 3V6 Canada
| | - Yunxiang He
- School of Chemistry, University of Bristol Bristol BS8 1TS UK
| | - Xu-Hui Jin
- School of Chemistry, University of Bristol Bristol BS8 1TS UK
- School of Chemistry and Chemical Engineering, Beijing Institute of Technology Beijing China
| | - Lorna Hodgson
- School of Biochemistry, University of Bristol Bristol BS8 1TD UK
| | - Paul Verkade
- School of Biochemistry, University of Bristol Bristol BS8 1TD UK
| | - Ian Manners
- School of Chemistry, University of Bristol Bristol BS8 1TS UK
- Department of Chemistry, University of Victoria Victoria BC V8W 3V6 Canada
| |
Collapse
|
10
|
Abstract
Good foot health throughout childhood is important but remains poorly understood with few studies exploring this topic. The aim of this study was to define parents' knowledge, practices and health-related perceptions of children's feet. A qualitative design was adopted. Semi-structured, one-to-one interviews were carried out with parents of children aged five years and under, recruited from South East and North West of England. Interviews explored parents' views, beliefs and understanding of foot health in infancy and early childhood. Transcripts of the interviews were analysed using thematic analysis. Eighteen interviews were conducted. Seven themes were identified relating to (1) parents belief and knowledge about children's foot health; (2) how parents use and share foot health information; (3) activities for supporting foot health and development; (4) footwear choices, beliefs and influences; (5) the way they access health professionals; (6) the way they search for foot health information and (7) developing practice(s) to support parents. The study provides the first insight into how parents view foot health in early infancy and childhood. The findings highlight the key foot health beliefs important to parents, how they learn about and what influences their decision-making about caring for children's feet, the way parents receive and seek information, and how they access support for foot health concerns. The findings highlight the need for accurate, clear and consistent foot health messages, and the important role health professionals have in signposting parents towards reliable and informative sources on foot health.
Collapse
Affiliation(s)
- L Hodgson
- School of Health Sciences, University of Brighton, Brighton, UK
| | - C Growcott
- School of Health and Society, University of Salford, Salford, UK
| | - A E Williams
- School of Health and Society, University of Salford, Salford, UK
| | - C J Nester
- School of Health and Society, University of Salford, Salford, UK
| | - S C Morrison
- School of Health Sciences, University of Brighton, Brighton, UK
| |
Collapse
|
11
|
Hodgson L, Growcott C, Williams A, Nester C, Morrison S. Multi-professional approaches to children's foot health: a qualitative study. Physiotherapy 2020. [DOI: 10.1016/j.physio.2020.03.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Han S, Raabe M, Hodgson L, Mantell J, Verkade P, Lasser T, Landfester K, Weil T, Lieberwirth I. High-Contrast Imaging of Nanodiamonds in Cells by Energy Filtered and Correlative Light-Electron Microscopy: Toward a Quantitative Nanoparticle-Cell Analysis. Nano Lett 2019; 19:2178-2185. [PMID: 30810045 PMCID: PMC6437650 DOI: 10.1021/acs.nanolett.9b00752] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Fluorescent nanodiamonds (fNDs) represent an emerging class of nanomaterials offering great opportunities for ultrahigh resolution imaging, sensing and drug delivery applications. Their biocompatibility, exceptional chemical and consistent photostability renders them particularly attractive for correlative light-electron microscopy studies providing unique insights into nanoparticle-cell interactions. Herein, we demonstrate a stringent procedure to image and quantify fNDs with a high contrast down to the single particle level in cells. Individual fNDs were directly visualized by energy-filtered transmission electron microscopy, that is, inside newly forming, early endosomal vesicles during their cellular uptake processes as well as inside cellular organelles such as a mitochondrion. Furthermore, we demonstrate the unequivocal identification, localization, and quantification of individual fNDs in larger fND clusters inside intracellular vesicles. Our studies are of great relevance to obtain quantitative information on nanoparticle trafficking and their various interactions with cells, membranes, and organelles, which will be crucial to design-improved sensors, imaging probes, and nanotherapeutics based on quantitative data.
Collapse
Affiliation(s)
- Shen Han
- Max-Planck Institute
for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
| | - Marco Raabe
- Max-Planck Institute
for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
- Institute of Inorganic
Chemistry I, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
| | - Lorna Hodgson
- School of Biochemistry, University of Bristol, Medical Sciences Building, University
Walk, BS8 1TD Bristol, United Kingdom
| | - Judith Mantell
- School of Biochemistry, University of Bristol, Medical Sciences Building, University
Walk, BS8 1TD Bristol, United Kingdom
| | - Paul Verkade
- School of Biochemistry, University of Bristol, Medical Sciences Building, University
Walk, BS8 1TD Bristol, United Kingdom
| | - Theo Lasser
- Max-Planck Institute
for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
- Laboratoire d’Optique Biomédical, École Polytechnique Fédérale
de Lausanne, CH-1015 Lausanne, Switzerland
| | - Katharina Landfester
- Max-Planck Institute
for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
| | - Tanja Weil
- Max-Planck Institute
for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
- Institute of Inorganic
Chemistry I, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
- E-mail:
(T.W.)
| | - Ingo Lieberwirth
- Max-Planck Institute
for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
- E-mail: (I.L.)
| |
Collapse
|
13
|
Chung GHC, Domart MC, Peddie C, Mantell J, Mclaverty K, Arabiotorre A, Hodgson L, Byrne RD, Verkade P, Arkill K, Collinson LM, Larijani B. Acute depletion of diacylglycerol from the cis-Golgi affects localized nuclear envelope morphology during mitosis. J Lipid Res 2018; 59:1402-1413. [PMID: 29895700 PMCID: PMC6071775 DOI: 10.1194/jlr.m083899] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2018] [Revised: 06/12/2018] [Indexed: 12/28/2022] Open
Abstract
Dysregulation of nuclear envelope (NE) assembly results in various cancers; for example, renal and some lung carcinomas ensue due to NE malformation. The NE is a dynamic membrane compartment and its completion during mitosis is a highly regulated process, but the detailed mechanism still remains incompletely understood. Previous studies have found that isolated diacylglycerol (DAG)-containing vesicles are essential for completing the fusion of the NE in nonsomatic cells. We investigated the impact of DAG depletion from the cis-Golgi in mammalian cells on NE reassembly. Using advanced electron microscopy, we observed an enriched DAG population of vesicles at the vicinity of the NE gaps of telophase mammalian cells. We applied a mini singlet oxygen generator-C1-domain tag that localized DAG-enriched vesicles at the perinuclear region, which suggested the existence of NE fusogenic vesicles. We quantified the impact of Golgi-DAG depletion by measuring the in situ NE rim curvature of the reforming NE. The rim curvature in these cells was significantly reduced compared with controls, which indicated a localized defect in NE morphology. Our novel results demonstrate the significance of the role of DAG from the cis-Golgi for the regulation of NE assembly.
Collapse
Affiliation(s)
- Gary Hong Chun Chung
- Cell Biophysics Laboratory, Ikerbasque Basque Foundation for Science, Research Centre for Experimental Marine Biology and Biotechnology (PiE) and Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Barrio Sarriena s/n 48940, Leioa, Spain
| | - Marie-Charlotte Domart
- Electron Microscopy Science Technology Platform, Francis Crick Institute, London, United Kingdom
| | - Christopher Peddie
- Electron Microscopy Science Technology Platform, Francis Crick Institute, London, United Kingdom
| | - Judith Mantell
- School of Biochemistry, Faculty of Biomedical Sciences, University of Bristol, Bristol, United Kingdom
| | - Kieran Mclaverty
- Cell Biophysics Laboratory, Ikerbasque Basque Foundation for Science, Research Centre for Experimental Marine Biology and Biotechnology (PiE) and Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Barrio Sarriena s/n 48940, Leioa, Spain
- School of Biochemistry, Faculty of Biomedical Sciences, University of Bristol, Bristol, United Kingdom
| | - Angela Arabiotorre
- Cell Biophysics Laboratory, Ikerbasque Basque Foundation for Science, Research Centre for Experimental Marine Biology and Biotechnology (PiE) and Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Barrio Sarriena s/n 48940, Leioa, Spain
| | - Lorna Hodgson
- School of Biochemistry, Faculty of Biomedical Sciences, University of Bristol, Bristol, United Kingdom
| | - Richard D Byrne
- Cell Biophysics Laboratory, Ikerbasque Basque Foundation for Science, Research Centre for Experimental Marine Biology and Biotechnology (PiE) and Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Barrio Sarriena s/n 48940, Leioa, Spain
| | - Paul Verkade
- School of Biochemistry, Faculty of Biomedical Sciences, University of Bristol, Bristol, United Kingdom
- Wolfson Bioimaging Facility, University of Bristol, Bristol, United Kingdom
| | - Kenton Arkill
- Cell Biophysics Laboratory, Ikerbasque Basque Foundation for Science, Research Centre for Experimental Marine Biology and Biotechnology (PiE) and Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Barrio Sarriena s/n 48940, Leioa, Spain
- Division of Cancer and Stem Cells, The Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom
| | - Lucy M Collinson
- Electron Microscopy Science Technology Platform, Francis Crick Institute, London, United Kingdom
| | - Banafshé Larijani
- Cell Biophysics Laboratory, Ikerbasque Basque Foundation for Science, Research Centre for Experimental Marine Biology and Biotechnology (PiE) and Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Barrio Sarriena s/n 48940, Leioa, Spain
| |
Collapse
|
14
|
Agbani EO, Williams CM, Li Y, van den Bosch MT, Moore SF, Mauroux A, Hodgson L, Verkman AS, Hers I, Poole AW. Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis. JCI Insight 2018; 3:99062. [PMID: 29769447 PMCID: PMC6012506 DOI: 10.1172/jci.insight.99062] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Accepted: 04/12/2018] [Indexed: 01/02/2023] Open
Abstract
In response to collagen stimulation, platelets use a coordinated system of fluid entry to undergo membrane ballooning, procoagulant spreading, and microvesiculation. We hypothesized that water entry was mediated by the water channel aquaporin-1 (AQP1) and aimed to determine its role in the platelet procoagulant response and thrombosis. We established that human and mouse platelets express AQP1 and localize to internal tubular membrane structures. However, deletion of AQP1 had minimal effects on collagen-induced platelet granule secretion, aggregation, or membrane ballooning. Conversely, procoagulant spreading, microvesiculation, phosphatidylserine exposure, and clot formation time were significantly diminished. Furthermore, in vivo thrombus formation after FeCl3 injury to carotid arteries was also markedly suppressed in AQP1-null mice, but hemostasis after tail bleeding remained normal. The mechanism involves an AQP1-mediated rapid membrane stretching during procoagulant spreading but not ballooning, leading to calcium entry through mechanosensitive cation channels and a full procoagulant response. We conclude that AQP1 is a major regulator of the platelet procoagulant response, able to modulate coagulation after injury or pathologic stimuli without affecting other platelet functional responses or normal hemostasis. Clinically effective AQP1 inhibitors may therefore represent a novel class of antiprocoagulant antithrombotics. AQP1 controls platelet procoagulant response and modulates coagulation after injury or pathologic stimuli without affecting other platelet functional responses or normal hemostasis.
Collapse
Affiliation(s)
- Ejaife O Agbani
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom.,Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Christopher M Williams
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Yong Li
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Marion Tj van den Bosch
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Samantha F Moore
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Adele Mauroux
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Lorna Hodgson
- Wolfson Bioimaging Facility, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Alan S Verkman
- Departments of Medicine and Physiology, University of California San Francisco, San Francisco, California, USA
| | - Ingeborg Hers
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| | - Alastair W Poole
- School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences Building, Bristol, United Kingdom
| |
Collapse
|
15
|
Abstract
Influenza A virus (IAV) entry is a stepwise process regulated by viral and cellular cues, facilitating cellular functions. Virus entry begins by attachment of hemagglutinin to cell surface sialic acids, followed by endocytic uptake, vesicular transport along microtubules, low-pH-mediated viral membrane fusion with the late endosomal membrane, capsid uncoating, viral ribonucleoprotein (vRNP) release, and nuclear import of vRNPs. Here we show a basic methodology to visualize incoming and egressing IAV particles by correlative light and electron microscopy (CLEM). We combine fluorescence microscopy of virus-infected human lung carcinoma A549 cells with high-pressure freezing (HPF) and in-resin fluorescence CLEM and the Tokuyasu CLEM method. This approach forms a basis to study the virus life cycle and virus-host interactions at the ultrastructural level.
Collapse
Affiliation(s)
- Lorna Hodgson
- School of Biochemistry, University of Bristol, Bristol, UK
| | - Paul Verkade
- School of Biochemistry, University of Bristol, Bristol, UK.,Wolfson Bioimaging Facility, University of Bristol, Bristol, UK
| | - Yohei Yamauchi
- School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
| |
Collapse
|
16
|
Lee MJ, Mantell J, Hodgson L, Alibhai D, Fletcher JM, Brown IR, Frank S, Xue WF, Verkade P, Woolfson DN, Warren MJ. Engineered synthetic scaffolds for organizing proteins within the bacterial cytoplasm. Nat Chem Biol 2017; 14:142-147. [DOI: 10.1038/nchembio.2535] [Citation(s) in RCA: 93] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Accepted: 11/01/2017] [Indexed: 12/21/2022]
|
17
|
Edelman M, Wang X, Hodgson L, Cheney R, Baggstrom M, Sachdev T, Gajra A, Bertino E, Reckamp K, Molina J, Schiller J, Mitchell-Edwards K, Friedman P, Ritter J, Milne G, Stinchcombe T, Hahn O, Vokes E. Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non–Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance). Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.01.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
18
|
Prewett S, Hodgson L, Gatfield E, Styling A, Gregory D, Russell S. Prostate Low Dose Rate Brachytherapy: the Cambridge Experience. Clin Oncol (R Coll Radiol) 2017. [DOI: 10.1016/j.clon.2016.11.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
19
|
Affiliation(s)
- L Hodgson
- Academic Orthopaedics, University of Nottingham, UK Corobeus Sports Consultancy Ltd, UK
| | - J Patricios
- Sports Concussion South Africa, Johannesburg, South Africa The Section of Sports Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa The Department of Emergency Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| |
Collapse
|
20
|
Abstract
During telophase, the nuclear envelope (NE) reforms around daughter nuclei to ensure proper segregation of nuclear and cytoplasmic contents1-4. NE reformation requires the coating of chromatin by membrane derived from the Endoplasmic Reticulum and a subsequent annular fusion step to ensure the formed envelope is sealed1,2,4,5. How annular fusion is accomplished is unknown, but it is thought to involve the p97 AAA-ATPase complex and bears a topological equivalence to the membrane fusion event that occurs during the abscission phase of cytokinesis1,6. We find here that the Endosomal Sorting Complex Required for Transport-III (ESCRT-III) machinery localises to sites of annular fusion in the forming NE and is necessary for proper post-mitotic nucleo-cytoplasmic compartmentalisation. The ESCRT-III component Charged Multivesicular Body Protein (CHMP) 2A is directed to the forming NE through binding to CHMP4B and provides an activity essential for NE reformation. Localisation also requires the p97 complex member Ubiquitin Fusion and Degradation 1 (UFD1). Our results describe a novel role for the ESCRT-machinery in cell division and demonstrate a conservation of the machineries involved in topologically equivalent mitotic membrane remodeling events.
Collapse
Affiliation(s)
- Yolanda Olmos
- Division of Cancer Studies, Section of Cell Biology and Imaging, King's College London, London SE1 1UL, UK
| | - Lorna Hodgson
- School of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK
| | - Judith Mantell
- 1] School of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK [2] Wolfson Bioimaging Facility, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK
| | - Paul Verkade
- 1] School of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK [2] Wolfson Bioimaging Facility, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK [3] School of Physiology &Pharmacology, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK
| | - Jeremy G Carlton
- Division of Cancer Studies, Section of Cell Biology and Imaging, King's College London, London SE1 1UL, UK
| |
Collapse
|
21
|
Hodgson L, Borowska A, Singer A, Bernie P, Potts J, Congleton J. S31 Predicting Death Or Deterioration In Patients Admitted With Acute Exacerbation Of Copd Using Physiological And Blood Parameters. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.37] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
22
|
Hodgson L, Tavaré J, Verkade P. Development of a quantitative Correlative Light Electron Microscopy technique to study GLUT4 trafficking. Protoplasma 2014; 251:403-16. [PMID: 24390248 PMCID: PMC3927059 DOI: 10.1007/s00709-013-0597-5] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Accepted: 12/12/2013] [Indexed: 05/21/2023]
Abstract
Correlative Light Electron Microscopy (CLEM) combines advantages of light microscopy and electron microscopy in one experiment to deliver information above and beyond the capability of either modality alone. There are many different CLEM techniques, each having its own special advantages but also its technical challenges. It is however the biological question that (should) drive(s) the development and application of a specific CLEM technique in order to provide the answer. Here we describe the development of a CLEM technique that is based on the Tokuyasu cryo immuno-gold labelling technique that has allowed us to quantitatively study GLUT4 trafficking.
Collapse
Affiliation(s)
- Lorna Hodgson
- School of Biochemistry, Medical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD UK
| | - Jeremy Tavaré
- School of Biochemistry, Medical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD UK
| | - Paul Verkade
- School of Biochemistry, Medical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD UK
- School of Physiology and Pharmacology, Medical Sciences Building, University Walk, Bristol, BS8 1TD UK
- Wolfson Bioimaging Facility, School of Medical Sciences, University Walk, Bristol, BS8 1TD UK
| |
Collapse
|
23
|
Hodgson L, Bax S, Montefort M, Zahra J, Venn R, Ranu H, Congleton J. S68 The National Early Warning Score (NEWS) & iatrogenic harm - could the NEWS for COPD patients be improved? Thorax 2013. [DOI: 10.1136/thoraxjnl-2013-204457.75] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Roh-Johnson M, Bravo-Cordero JJ, Patsialou A, Sharma VP, Guo P, Liu H, Hodgson L, Condeelis J. Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. Oncogene 2013; 33:4203-12. [PMID: 24056963 PMCID: PMC3962803 DOI: 10.1038/onc.2013.377] [Citation(s) in RCA: 139] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2013] [Revised: 07/01/2013] [Accepted: 07/16/2013] [Indexed: 12/23/2022]
Abstract
Most cancer patients die as a result of metastasis, thus it is important to understand the molecular mechanisms of dissemination, including intra- and extravasation. Although the mechanisms of extravasation have been vastly studied in vitro and in vivo, the process of intravasation is still unclear. Furthermore, how cells in the tumor microenvironment facilitate tumor cell intravasation is still unknown. Using high-resolution imaging, we found that macrophages enhance tumor cell intravasation upon physical contact. Macrophage and tumor cell contact induce RhoA activity in tumor cells, triggering the formation of actin-rich degradative protrusions called invadopodia, enabling tumor cells to degrade and break through matrix barriers during tumor cell transendothelial migration. Interestingly, we show that macrophage-induced invadopodium formation and tumor cell intravasation also occur in patient-derived tumor cells and in vivo models, revealing a conserved mechanism of tumor cell intravasation. Our results illustrate a novel heterotypic cell contact mediated signaling role for RhoA, as well as yield mechanistic insight into the ability of cells within the tumor microenvironment to facilitate steps of the metastatic cascade.
Collapse
Affiliation(s)
- M Roh-Johnson
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| | - J J Bravo-Cordero
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| | - A Patsialou
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| | - V P Sharma
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| | - P Guo
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| | - H Liu
- The Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA
| | - L Hodgson
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| | - J Condeelis
- 1] Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA [2] Gruss-Lipper Biophotonics Center, Bronx, NY, USA
| |
Collapse
|
25
|
Townley AK, Schmidt K, Hodgson L, Stephens DJ. Epithelial organization and cyst lumen expansion require efficient Sec13-Sec31-driven secretion. J Cell Sci 2012; 125:673-84. [PMID: 22331354 DOI: 10.1242/jcs.091355] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Epithelial morphogenesis is directed by interactions with the underlying extracellular matrix. Secretion of collagen and other matrix components requires efficient coat complex II (COPII) vesicle formation at the endoplasmic reticulum. Here, we show that suppression of the outer layer COPII component, Sec13, in zebrafish embryos results in a disorganized gut epithelium. In human intestinal epithelial cells (Caco-2), Sec13 depletion causes defective epithelial polarity and organization on permeable supports. Defects are seen in the ability of cells to adhere to the substrate, form a monolayer and form intercellular junctions. When embedded in a three-dimensional matrix, Sec13-depleted Caco-2 cells form cysts but, unlike controls, are defective in lumen expansion. Incorporation of primary fibroblasts within the three-dimensional culture substantially restores normal morphogenesis. We conclude that efficient COPII-dependent secretion, notably assembly of Sec13-Sec31, is required to drive epithelial morphogenesis in both two- and three-dimensional cultures in vitro, as well as in vivo. Our results provide insight into the role of COPII in epithelial morphogenesis and have implications for the interpretation of epithelial polarity and organization assays in cell culture.
Collapse
Affiliation(s)
- Anna K Townley
- Cell Biology Laboratories, School of Biochemistry, Medical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD, UK
| | | | | | | |
Collapse
|
26
|
Hodgson L, Doffman S, Baldock E, Sharma N, Messenger J. 84 Investigating and managing patients with pleural disease within an ambulatory care setting to prevent hospital admissions. Lung Cancer 2012. [DOI: 10.1016/s0169-5002(12)70085-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
27
|
Morgan HK, Hodgson L, Baldock E, Doffman SR. P195 Outcomes in emergency admissions with lung cancer: a 1-year perspective from a teaching hospital. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054c.195] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
28
|
Hodgson L, Fairhurst A, Thorburn P, Frew AF, Doffman SR. P127 Improving smoking cessation advice through the implementation of a quality improvement intervention. Thorax 2011. [DOI: 10.1136/thoraxjnl-2011-201054c.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
29
|
Salama JK, Hodgson L, Pang H, Green MR, Urbanic JJ, Blackstock AW, Crawford J, Bogart J, Vokes EE. Predictors of pulmonary toxicity in limited-stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high-dose (70 Gy) daily radiotherapy (RT): A pooled analysis of three CALGB studies. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7078] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
30
|
Hodgson L, Doffman S, Messenger J, Mason L. 60 The use of distress scores in a dedicated lung cancer clinic. Lung Cancer 2011. [DOI: 10.1016/s0169-5002(11)70060-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Edelman MJ, Hodgson L, Wang XF, Christenson R, Vokes EE, Kratzke RA. Serum VEGF and COX-2/5LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Grauslund J, Hodgson L, Kawasaki R, Green A, Sjølie AK, Wong TY. Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes. Diabetologia 2009; 52:2213-7. [PMID: 19618163 DOI: 10.1007/s00125-009-1459-8] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2009] [Accepted: 06/22/2009] [Indexed: 10/20/2022]
Abstract
AIMS/HYPOTHESIS The purpose of the study was to evaluate the association between retinal vascular calibre and micro- and macrovascular complications in a population-based cohort of Danish type 1 diabetic patients. METHODS This was a cross-sectional study of 208 long-surviving type 1 diabetic patients from a population-based Danish cohort. Retinal photographs were obtained at a clinical examination attended by each participant in 2007-2008, and retinal vascular calibre was measured and summarised as the central retinal artery or vein equivalent (CRAE or CRVE) using a computer-based program and a standardised protocol. Associations between retinal vascular calibre and micro- and macrovascular complications were examined after adjusting for confounding clinical characteristics. RESULTS Retinal photographs were gradable for 188 of 208 patients (90.3%). The median age and duration of diabetes for patients with gradable photos were 57.9 and 42 years, respectively. After multivariate adjustments, individuals with narrower retinal arterioles were more likely to have nephropathy (OR 2.17, 95% CI 1.29-3.68, per SD decrease in CRAE) and macrovascular disease (OR 3.17, 95% CI 1.59-6.34, per SD decrease in CRAE), but not neuropathy (OR 1.10, 95% CI 0.70-1.71, per SD decrease in CRAE). Retinal venular calibre was not associated with any micro- or macrovascular complications. CONCLUSIONS/INTERPRETATION In type 1 diabetic patients, retinal arteriolar narrowing is associated with nephropathy and macrovascular disease independently of other clinical characteristics. If supported by further prospective studies, measurement of retinal vessel diameter may allow a non-invasive evaluation of the risk of diabetes-related complications.
Collapse
Affiliation(s)
- J Grauslund
- Department of Ophthalmology, Odense University Hospital, Denmark.
| | | | | | | | | | | |
Collapse
|
33
|
Rosenblatt PY, Edelman MJ, Christenson RH, Hodgson L, Wang X, Kratzke R, Vokes E. CYFRA 21–1 (CYFRA) as a prognostic and predictive marker in advanced non-small cell lung cancer (NSCLC): CALGB 150304. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.11020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11020 Background: Cytokeratin 19 and its soluble fragment CYFRA have been studied as markers that may correlate with response to therapy and survival in NSCLC. As part of CALGB 30203, a randomized trial of carboplatin/gemcitabine with eicosanoid modulators (celecoxib, zileuton or both) in advanced NSCLC (Edelman JCO 2008), serum CYFRA levels were obtained prior to and during treatment. The objective of this study was to evaluate the possible correlation of CYFRA as a predictive and prognostic marker and to confirm a previous finding that a 27% reduction in CYFRA after one cycle (21 days) of treatment correlated with a longer survival (Vollmer Clin Ca Res, 2003). Methods: Paired specimens were available from 88 patients. CYFRA was measured at baseline and after cycles 1 and 2 using an electrochemoluminescent assay (Roche Diagnostics) on the ElecSys 2010 system as previously described. Using logarithm of the initial concentration and logarithm of the difference in concentrations, we analyzed these in relation to overall survival (OS) and failure free survival (FFS). Results: 1. Lower baseline CYFRA levels were associated with both longer overall survival and failure free survival (p = <0.0001 and p=0.0045). 2. Larger reductions in CYFRA levels correlated to longer overall survival and failure-free survival (p=0.0254 and p=0.0298). 3.We failed to replicate that a drop of >27% in CYFRA levels had statistical significance in overall or failure free survival (p=0.6489 and p=0.9636). Conclusions: CYFRA and change in CYFRA appear to be reliable markers in predicting the response to chemotherapy for nonsmall cell lung cancer; however, a precise threshold to mark response has yet to be determined. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. Y. Rosenblatt
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - M. J. Edelman
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - R. H. Christenson
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - L. Hodgson
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - X. Wang
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - R. Kratzke
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - E. Vokes
- University of Maryland, Baltimore, MD; University of Maryland Greenebaum Cancer Center, Baltimore, MD; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| |
Collapse
|
34
|
Stinchcombe TE, Hodgson L, Herndon JE, Kelley MJ, Cicchetti M, Ramnath N, Niell HB, Atkins JN, Green MR, Vokes EE. Clinical factors predictive of overall survival (OS) and the identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7535 Background: CALGB 39801 was designed to test whether treatment with induction chemotherapy and concurrent chemoradiotherapy (arm B) would improve OS in comparison to identical chemoradiotherapy alone (arm A), and demonstrated no significant benefit in OS for induction therapy. The objective of this analysis was to identify factors predictive of OS, and to use relevant factors to dichotomize pts into prognostic groups. Methods: Between July 1998 and May 2002, 331 pts were studied and included in a Cox proportional hazard regression analysis investigating previously identified prognostic factors: age (< 70 vs. ≥ 70 years), gender, race/ethnicity, hemoglobin (hgb) (< 13 vs. ≥13), performance status (PS) (0 vs.1), pretreatment weight loss (wt loss) (<5% vs. ≥ 5%), and treatment arm. Results: Cox regression analysis identified weight loss ≥ 5%, age ≥ 70, PS of 1, and hgb < 13 as predictive of worse survival (p<0.05), but not treatment arm (p=0.55). The median survival for pts with 0 (n=66), 1 (n=100), 2 (n=100), or ≥ 3 (n=65) risk factors were 24, 18, 10, and 8 months, respectively (p=0.0001). The pts were dichotomized into “poor prognosis” (PP) defined as ≥2 factors (n=165) and “good prognosis” (GP) defined as ≤ 1 factors (n=166). The hazard ratio (HR) for overall survival for the PP in comparison GP was 1.88 (95% CI, 1.49 to 2.37; p-value < 0.0001); the median survival times (MST) observed were 9 and 18 months, respectively (p<0.0001). The reasons for discontinuing treatment, and the rates of hematologic and non-hematologic adverse events were similar between the two groups. In the PP group the OS was similar between arms A (n=82) and B (n=83) (HR=0.97, 95% CI, 0.70 to 1.4; p=0.34); MST of 8.7 and 9.5 months, respectively. In the GP the OS was similar between arms A (n=79) and B (n=87) (HR=0.86, 95% CI, 0.63 to 1.1; p=0.87); MST of 19.3 and 17.6 months, respectively. Conclusions: Factors predictive of OS can be used to dichotomize pts into prognostic groups. Induction chemotherapy was not beneficial in either prognostic group. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- T. E. Stinchcombe
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - L. Hodgson
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - J. E. Herndon
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - M. J. Kelley
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - M. Cicchetti
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - N. Ramnath
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - H. B. Niell
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - J. N. Atkins
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - M. R. Green
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| | - E. E. Vokes
- University of North Carolina, Chapel Hill, NC; CALGB Statistical Center, Durham, NC; Duke University Medical Center, Durham, NC; University of Massachusetts Medical School, Worcester, MA; Roswell Park Cancer Institute, Buffalo, NY; University of Tennessee Memphis, Memphis, NC; Wake Forest University School of Medicine, Winston-Salem, NC; Medical University of South Carolina, Charleston, SC; University of Chicago, Chicago, IL
| |
Collapse
|
35
|
Govindan R, Bogart J, Wang X, Hodgson L, Kratzke R, Vokes EE. Phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small cell lung cancer: CALGB 30407. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.7505] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7505 Background: Cisplatin, etoposide and concurrent thoracic radiation has remained the standard treatment for locally advanced unresectable non small cell lung cancer (NSCLC) over the past two decades. The Cancer and Leukemia Group B (CALGB) conducted a phase II study using a novel chemotherapy regimen administered in systemically active doses with thoracic radiation (CALGB 30407). We previously reported the preliminary safety results (ASCO 2008, abstract 7518). Methods: Eligible patients with previously untreated stage III NSCLC received thoracic radiation (70 Gy) along with carboplatin (AUC 5) and pemetrexed 500 mg/m2 on day 1 administered intravenously every 21 days for 4 cycles (arm A) or the same chemotherapy regimen with weekly cetuximab for 6 weeks concurrent with radiation (arm B). All patients received four additional cycles of pemetrexed (500 mg/m2 every 21 days) as consolidation therapy. The primary endpoint was the percentage of patients who lived longer than 18 months after starting initial treatment. We planned to study the regimen (s) further if the 18 month survival rates equaled or exceeded 55%. Results: Characteristics of the 99 eligible pts (48 in arm A and 51 arm B) enrolled from 09/05 to 1/08: male 62%, 22% were 70 yrs or older. The most common histological type was adenocarcinoma (46% in Arm A and 41% in Arm B). Updated toxicity data (grade 3 or greater, %) by arms (arm A/arm B) for 106 pts: neutropenia 40/47; febrile neutropenia 8/6, thrombocytopenia 36/34, nausea/vomiting 8/10, esophagitis 32/24, skin rash 2/21 and fatigue 22/17. The median follow up time is 17 months. Preliminary efficacy data by arms (arm A/arm B) for 99 pts: complete or partial response 73% (95% CI 59–83)/71% (95% CI 57–81%), median failure free survival (months) 12.9 (95% CI 8.6–18.0)/10.3 (95% CI 8.7–18.9); 18 month survival 57% (95% CI 41–79)/47% (95% CI 33–67) and median survival (months) 22.3/18.7. Conclusions: The combination of pemetrexed, carboplatin and thoracic radiation has met the protocol-specified criteria for further study. Although it does not appear that the addition of cetuximab confers additional benefit in this setting, further follow-up is necessary. [Table: see text]
Collapse
Affiliation(s)
- R. Govindan
- Washington University School of Medicine, St. Louis, MO; State University of New York, New York, NY; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - J. Bogart
- Washington University School of Medicine, St. Louis, MO; State University of New York, New York, NY; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - X. Wang
- Washington University School of Medicine, St. Louis, MO; State University of New York, New York, NY; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - L. Hodgson
- Washington University School of Medicine, St. Louis, MO; State University of New York, New York, NY; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - R. Kratzke
- Washington University School of Medicine, St. Louis, MO; State University of New York, New York, NY; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| | - E. E. Vokes
- Washington University School of Medicine, St. Louis, MO; State University of New York, New York, NY; Duke University, Durham, NC; University of Minnesota, Minneapolis, MN; University of Chicago, Chicago, IL
| |
Collapse
|
36
|
Janne PA, Wang XF, Krug LM, Hodgson L, Vokes EE, Kindler HL. Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307). J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.7707] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7707 Background: Systemic chemotherapy with cisplatin/pemetrexed is the approved first line treatment regimen for patients with MM. There is no approved second line therapy. In addition, many patients, especially those >70, cannot tolerate combination chemotherapy. Angiogenesis inhibitors have emerged as attractive potential therapies for MM and SU5416 and PTK787 have previously demonstrated single agent activity. We examined the efficacy of sorafenib, an inhibitor of VEGFR2 and PDGFR-b, in chemotherapy naïve and previously treated patients with MM. Methods: This was an open label single arm phase II study of sorafenib in chemotherapy naïve and previously pemetrexed treated patients with MM. Primary end point was response rate (RR). Secondary objectives were 3-month failure free and overall survival (FFS and OS). Forty-four (44) eligible patients were expected to enroll to differentiate a RR of <5% versus >20%, with a Type I error of 0.0675 and a power of 0.955 Results: Between 10/04 and 8/05, 51 patients were enrolled and treated with sorafenib 400 mg bid. One cycle was defined as 28 days; restaging occurred every 2 cycles. Baseline demographics: M/F (36/15); Median age (69; range 36–88; 45% >70); Histology (epithelial/sarcomatoid/mixed/unknown: 37/4/8/2); pleural/peritoneal MM (46/5); ECOG PS 0/1 (11/40); chemo-naive/prior chemo (20/31). Grade 3/4 toxicities occurring in >10% of patients: Fatigue (12 (25%); 11/1) and hand-foot reaction (6 (13%); 6/0). No study related deaths occurred. Estimates of RR and FFS are based on 47 patients with available follow-up data. Response: CR: 0; PR 2: 4% (95% CI; 1- 14%); SD 28 (60%); PD 11 (23%); unevaluable 6 (14%). Three month FFS was 78%; median FFS was 3.7 months and median OS was 10.7 months. The median FFS were 3.6 and 3.6 months and the median OS were 4.9 and 14.6 months in chemo naïve and previously treated patients, respectively. Conclusions: Sorafenib demonstrated modest activity in this phase II trial but did not meet its primary endpoint. The improved outcome in previously treated patients likely reflects patient selection. Ongoing correlative science studies including expression of p-ERK 1/2, baseline VEGF and PDGF levels, are being performed to help identify patient subsets who may benefit (PR or SD) from sorafenib. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. A. Janne
- Dana-Farber Cancer Institute, Boston, MA; Duke University, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Chicago, Chicago, IL
| | - X. F. Wang
- Dana-Farber Cancer Institute, Boston, MA; Duke University, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Chicago, Chicago, IL
| | - L. M. Krug
- Dana-Farber Cancer Institute, Boston, MA; Duke University, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Chicago, Chicago, IL
| | - L. Hodgson
- Dana-Farber Cancer Institute, Boston, MA; Duke University, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Chicago, Chicago, IL
| | - E. E. Vokes
- Dana-Farber Cancer Institute, Boston, MA; Duke University, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Chicago, Chicago, IL
| | - H. L. Kindler
- Dana-Farber Cancer Institute, Boston, MA; Duke University, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Chicago, Chicago, IL
| |
Collapse
|
37
|
Powers PS, Kolodney E, Hodgson L, Ziegler G, Reisler H, Wittig C. Effect of surface temperature on collision-induced dissociation of 1,1,1,2,3,3,3-heptafluoro-2-nitrosopropene scattered from magnesium oxide (100), gallium arsenide (100), and silver (111). ACTA ACUST UNITED AC 2002. [DOI: 10.1021/j100174a064] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
38
|
Abstract
We have investigated cellular Ca2+ regulation during A2058 human melanoma cell chemotaxis to type IV collagen (CIV). We have identified alpha2beta1-integrin as the primary mediator of A2058 cell response to CIV in vitro. Integrin ligation initiated a characteristic intracellular Ca2+ concentration ([Ca2+]i) response consisting of an internal release and a receptor-mediated Ca2+ entry. Thapsigargin (TG) pretreatment drained overlapping and CIV-inducible internal Ca2+ stores while initiating a store-operated Ca2+ release (SOCR). CIV-mediated Ca2+ entry was additive to TG-SOCR, suggesting an independent signaling mechanism. Similarly, ionophore application in a basal medium containing Ca2+ initiated a sustained influx. Elevated [Ca2+]i from TG-SOCR or ionophore significantly attenuated cell migration to CIV by recruiting the Ca2+/calcineurin-mediated signaling pathway. Furthermore, low [Ca2+]i induced by EGTA application in the presence of ionophore fully restored cell motility to CIV. Together, these results suggest that [Ca2+]i signaling accompanying A2058 cell response to alpha2beta1-integrin ligation is neither necessary nor sufficient and that elevated [Ca2+]i downregulates cell motility via a calcineurin-mediated mechanism in A2058 cell chemotaxis to CIV.
Collapse
Affiliation(s)
- L Hodgson
- Department of Bioengineering, Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | | |
Collapse
|
39
|
Abstract
OBJECTIVE To compare the pain relief, sedation, and common side effect profiles of ketorolac tromethamine and meperidine for the management of acute pain in the emergency department (ED). METHODS A prospective, double-blind, randomized clinical trial was conducted over a 12-month period using consecutive adult patients presenting to a university teaching hospital ED (annual census: 32,000), who required IM analgesia for acute pain. Adult patients with acute pain of various etiologies were randomly assigned to receive a single fixed IM dose of ketorolac (60 mg) or meperidine (100 mg). RESULTS Ninety-three patients were enrolled in the study; 46 were randomized to meperidine and 47 to ketorolac. Using a visual analog scale, there was no difference in pain relief between the ketorolac and meperidine groups even after adjusting for baseline pain level. Ketorolac caused significantly (p < 0.005) less sedation than did meperidine at one hour. Rescue analgesia was required for seven of the 46 (15.2%) patients receiving meperidine and five of the 47 (10.6%) patients receiving ketorolac (p = NS). Seventeen of 45 (38%) patients receiving meperidine experienced side effects compared with eight of the 47 (17%) patients receiving ketorolac (p = 0.0452). CONCLUSIONS When used to treat patients who had acute pain states, 60 mg of IM ketorolac produced analgesia similar to that produced by 100 mg of IM meperidine; however, the ketorolac produced fewer subjective side effects and less sedation than did the meperidine.
Collapse
Affiliation(s)
- K L Koenig
- Highland Hospital Emergency Department, Oakland, CA 94602, USA
| | | | | | | | | | | |
Collapse
|
40
|
Ferkel H, Hodgson L, Singleton JT, Blass PM, Reisler H, Wittig C. 365 nm photon‐induced dynamics of ClNO adsorbed on MgO(100). J Chem Phys 1994. [DOI: 10.1063/1.466676] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
|
41
|
Abstract
The 365 nm pulsed laser photolysis of nitrosyl chloride adsorbed on a rough MgO(100) surface at 90 K has been studied. Mass spectrometric detection was used to record time-of-flight (TOF) spectra by monitoring Cl+ and NO+. These ions can derive from parent ClNO, which fragments completely in the mass spectrometer, as well as from Cl and NO photofragments. The TOF distributions are considerably slower than for the corresponding gas phase photodissociation process. NO was also detected state selectively by using resonance enhanced multiphoton ionization (REMPI), and a channel corresponding to direct adsorbate photolysis was identified. The state selective detection of NO molecules that emerge from the surface following photolysis shows unambiguously that their rotational degrees of freedom reflect the surface temperature (Trot = 100−140 K), even at low coverages. At similar photolysis wavelengths, gas phase ClNO photodissociation is known to produce highly rotationally excited NO with a distinctive non-statistical distribution peaked at J″ = 46.5. Our studies suggest that, contrary to the gas-phase photolysis results, Cl and NO are not ejected rapidly following photolysis of surface-bound species on a repulsive potential energy surface. We postulate that ClNO grows in islands, with MgO defect sites serving as nucleation centers. Photofragment rotational and translational excitations are quenched efficiently due to strong attractive interactions that equilibrate NO to the surface temperature. Desorption of intact ClNO may also take place, but following (i.e., not during) the photolysis pulse. Such desorbed species can contribute to the TOF spectra, but not the REMPI spectra.
Collapse
|
42
|
Hodgson L, Hardern R. Use of a telephone advice line in an A and E department. West J Med 1994. [DOI: 10.1136/bmj.308.6927.537b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
43
|
Kolodney E, Powers PS, Hodgson L, Reisler H, Wittig C. NO(X 2Π) product state distributions in molecule–surface collision‐induced dissociation: Direct inelastic scattering of n,i‐C3F7NO from MgO(100) at Eincident≤7.0 eV. J Chem Phys 1991. [DOI: 10.1063/1.459905] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|